Ulrika Berglund appointed Head of External Affairs

Report this content

Ulrika Berglund has been appointed Head of External Affairs at Bactiguard and will be responsible for communications and public affairs. She succeeds Cecilia Edström, who will assume an extended responsibility for sales and business development.

“I am very pleased with the recruitment of Ulrika Berglund to Bactiguard. With her extensive media experience and broad network in the Life Science industry, she will contribute to strengthening the company’s position, not least in the Swedish market”, says Christian Kinch CEO. 

“At the same time, Cecilia Edström will be able to focus on the important task of driving sales of our product portfolio and developing new business opportunities”, Christian Kinch continues.

Since 2012, Ulrika Berglund has been Business Area Director at the B2B publishing house Mentor Communications. She brought  with her the Swedish magazines Medtech Magazine and Labtech Magazine, which she founded and ran for several years. She has close to 20 years of experience from the pharmaceutical and medtech industry, most recently as Director of the business areas health/healthcare and retail at Mentor Communications. Ulrika Berglund assumes her new position at Bactiguard on September 28.

“I am very excited about working with a Swedish innovation, which makes a difference to people all over the world, in a global market. Bactiguard has come a long way during its first 10 years. There have been a lot of challenges but the opportunities are even greater and I am looking forward to being part of the company's journey”, says Ulrika Berglund.

For further information, please contact:
Susann Remnert, Communication Manager, mobile: 46 709 195 342

About Bactiguard
Bactiguard is a Swedish medtech company with a mission of preventing healthcare associated infections, reducing the use of antibiotics and saving lives by developing and supplying infection prevention solutions for the healthcare industry. The company’s patented coating prevents healthcare associated infections by reducing bacterial adhesion and growth on medical devices. Bactiguard®-coated urinary catheters are market leading in the US and Japan, and in recent years the company has developed its own product portfolio of catheters for the urinary and respiratory tract and the blood stream. Bactiguard is currently in a strong expansion phase, focused on new markets in the Europe, Middle East, Asia, Latin America and Southern Africa. The company has market presence in some 50 countries and has about 60 employees. Its headquarters is located in Stockholm and production facilities in Sweden and Malaysia. Bactiguard is listed on Nasdaq Stockholm. Read more about Bactiguard at www.bactiguard.com

Tags: